137 related articles for article (PubMed ID: 5316913)
21. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
Dodt J; Costanzo A; Daas A; Hunfeld A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
[TBL] [Abstract][Full Text] [Related]
22. International biological standards for coagulation factors and inhibitors.
Hubbard AR
Semin Thromb Hemost; 2007 Apr; 33(3):283-9. PubMed ID: 17427063
[TBL] [Abstract][Full Text] [Related]
23. Standardization of Factor VIII. I. Calibration of British Standards for Factor VIII clotting activity.
Barrowcliffe TW; Kirkwood TB
Br J Haematol; 1980 Nov; 46(3):471-81. PubMed ID: 6778499
[TBL] [Abstract][Full Text] [Related]
24. Factor VIII concentrate for hemophilia: comparison of two heat-treated products.
Walker IR; Pai MK; Blair BA; Johnston MA; Birkett NJ; Ofosu FA; Naylor DH
CMAJ; 1987 Jan; 136(2):150-2. PubMed ID: 3098401
[TBL] [Abstract][Full Text] [Related]
25. A collaborative study to establish the 6th International Standard for factor VIII concentrate.
Raut S; Heath AB; Barrowcliffe TW
Thromb Haemost; 2001 Jun; 85(6):1071-8. PubMed ID: 11434687
[TBL] [Abstract][Full Text] [Related]
26. A collaborative study to establish the 7th International Standard for Factor VIII Concentrate.
Raut S; Bevan S; Hubbard AR; Sands D; Barrowcliffe TW
J Thromb Haemost; 2005 Jan; 3(1):119-26. PubMed ID: 15634275
[TBL] [Abstract][Full Text] [Related]
27. Performance of recalibrated ReFacto laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto (B-domain deleted recombinant factor VIII).
Santoro C; Iorio A; Ferrante F; Pallotta A; Pignoloni P; Biondo F; Agnelli G; Mazzucconi MG
Haemophilia; 2009 May; 15(3):779-87. PubMed ID: 19298379
[TBL] [Abstract][Full Text] [Related]
28. Factor VIII concentrate: a comparison of manufacturers' assays and users' assays. Report of a survey carried out on behalf of the ICTH subcommittee on Factor VIII activities.
Rizza CR
Thromb Haemost; 1983 Oct; 50(3):753-4. PubMed ID: 6417822
[No Abstract] [Full Text] [Related]
29. Standardization of Factor VIII. II. A British Standard for Factor VIII related antigen.
Kirkwood TB; Barrowcliffe TW
Br J Haematol; 1980 Nov; 46(3):483-90. PubMed ID: 6778500
[TBL] [Abstract][Full Text] [Related]
30. Standardization of factor IX: standards for "purified" factor IX concentrates.
Lamb MA; Fricke WA; Rastogi SC
Thromb Haemost; 1991 Nov; 66(5):548-51. PubMed ID: 1803618
[TBL] [Abstract][Full Text] [Related]
31. In vivo recovery of factor VIII: a comparison of one-stage and two-stage assay methods.
Nilsson IM; Kirkwood TB; Barrowcliffe TW
Thromb Haemost; 1979 Dec; 42(4):1230-9. PubMed ID: 120619
[TBL] [Abstract][Full Text] [Related]
32. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
[TBL] [Abstract][Full Text] [Related]
33. Freeze-dried whole plasma: evaluating sucrose, trehalose, sorbitol, mannitol and glycine as stabilizers.
Bakaltcheva I; O'Sullivan AM; Hmel P; Ogbu H
Thromb Res; 2007; 120(1):105-16. PubMed ID: 16962645
[TBL] [Abstract][Full Text] [Related]
34. In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparations.
Toolis F; McKay G; Prowse CV
Thromb Haemost; 1980 Feb; 43(1):25-7. PubMed ID: 6773169
[TBL] [Abstract][Full Text] [Related]
35. von Willebrand factor standards for plasma and concentrate testing.
Hubbard AR
Semin Thromb Hemost; 2006 Jul; 32(5):522-8. PubMed ID: 16862526
[TBL] [Abstract][Full Text] [Related]
36. Factor VIII-related activities in therapeutic concentrates.
Barrowcliffe TW; Kemball-Cook G; Morris G; Holt JC; Furlong RA; Peake IR
J Lab Clin Med; 1981 Mar; 97(3):429-38. PubMed ID: 6780643
[TBL] [Abstract][Full Text] [Related]
37. Establishment of the 2nd Korean national biological reference standard for blood coagulation factor VIII:C concentrate.
Lee N; Seo JS; Kim JO; Ban SJ
Biologicals; 2017 May; 47():59-63. PubMed ID: 28087107
[TBL] [Abstract][Full Text] [Related]
38. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
Meager A; Das RG
J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
[TBL] [Abstract][Full Text] [Related]
39. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
Lundblad RL; Kingdon HS; Mann KG; White GC
Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
[TBL] [Abstract][Full Text] [Related]
40. Heparin neutralization is essential for accurate measurement of factor VIII activity and inhibitor assays in blood samples drawn from implanted venous access devices.
Manco-Johnson MJ; Nuss R; Jacobson LJ
J Lab Clin Med; 2000 Jul; 136(1):74-9. PubMed ID: 10882230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
